Determinants of depression in patients with comorbid depression following cardiac rehabilitation by Sever, Serdar et al.
This is a repository copy of Determinants of depression in patients with comorbid 
depression following cardiac rehabilitation.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/145017/
Version: Published Version
Article:
Sever, Serdar, Harrison, Alexander Stephen orcid.org/0000-0002-2257-6508, Golder, 
Susan Pamela orcid.org/0000-0002-8987-5211 et al. (1 more author) (2019) Determinants 
of depression in patients with comorbid depression following cardiac rehabilitation. Open 
Heart. ISSN 2053-3624 
https://doi.org/10.1136/ openhrt-2018-000973
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Open access 
  1Sever S, et al. Open Heart 2019;6:e000973. doi:10.1136/openhrt-2018-000973
To cite: Sever S, Harrison AS, 
Golder S, et al. Determinants of 
depression in patients with 
comorbid depression following 
cardiac rehabilitation. Open 
Heart 2019;6:e000973. 
doi:10.1136/
openhrt-2018-000973
Received 19 November 2018
Revised 23 January 2019
Accepted 4 March 2019
Health Sciences, University of 
York, York, UK
Correspondence to
Serdar Sever;  ss2284@ york. 
ac. uk
Determinants of depression in patients 
with comorbid depression following 
cardiac rehabilitation
Serdar Sever,   Alexander Stephen Harrison, Su Golder, Patrick Doherty
Cardiac risk factors and prevention
© Author(s) (or their 
employer(s)) 2019. Re-use 
permitted under CC BY. 
Published by BMJ.
Key questions
What is already known about this subject?
 Ź A prior history of depression is associated with poor 
cardiac rehabilitation outcomes; however, little is 
known about which factors play a part in determin-
ing the extent of beneit after cardiac rehabilitation 
in patients with history of depression.
What does this study add?
 Ź This study is the irst to identify and evaluate the 
factors that determine cardiac rehabilitation de-
pression outcomes in patients with prior history of 
depression and inform future cardiac rehabilitation 
practice.
How might this impact on clinical practice?
 Ź Cardiac rehabilitation programmes need to be 
aware of patients with history of depression and 
their modiiable baseline patient characteristics 
such as anxiety, smoking and physical inactivity 
associated with outcomes to ensure patients with 
history of depression gain the most from CR pro-
grammes and improve their depression levels after 
cardiac rehabilitation.
ABSTRACT
Background A prior history of depression, at the point 
patients start cardiac rehabilitation (CR), is associated 
with poor outcomes; however, little is known about which 
factors play a part in determining the extent of beneit 
following CR. Therefore, we aim to identify and evaluate 
determinants of CR depression outcomes in patients with 
comorbid depression.
Methods An observational study of routine practice using 
the British Heart Foundation National Audit of Cardiac 
Rehabilitation data between April 2012 and March 2017. 
Baseline characteristics were examined with independent 
samples t-test and χ2 test. A binary logistic regression was 
used to predict change in depression outcome following 
CR.
Results The analysis included 2715 CR participants with 
depression history. The determinants of Hospital Anxiety 
and Depression Scale (HADS) depression measurement 
post-CR were higher total number of comorbidities (OR 
0.914, 95% CI 0.854 to 0.979), a higher HADS anxiety 
score (OR 0.883, 95% CI 0.851 to 0.917), physical 
inactivity (OR 0.707, 95% CI 0.514 to 0.971), not-smoking 
at baseline (OR 1.774, 95% CI 1.086 to 2.898) and male 
gender (OR 0.721, 95% CI 0.523 to 0.992).
Conclusion Baseline characteristics of patients with 
comorbid depression such as higher anxiety, higher total 
number of comorbidities, smoking, physical inactivity 
and male gender were predictors of their depression 
levels following CR. CR programmes need to be aware 
of comorbid depression and these related patient 
characteristics associated with better CR outcomes.
INTRODUCTION
Cardiovascular disease (CVD) constitutes 
the highest mortality rate among all causes 
of death and is responsible for 17.9 million 
deaths around the world in 20161 and 
approximately 152 500 deaths in the UK in 
2016.2 Additionally, 83.5 million people in 
European Society of Cardiology member 
countries continue to live with CVD.3 Due to 
increased survival rates in CVD and an ageing 
population, there has been an increase in the 
number of comorbidities present with CVD 
which further complicates the management 
of a patient’s condition and service delivery 
options.4 Depression is reported to be a 
prevalent comorbidity in cardiac patients; 
the prevalence of depression ranges from 
15%–20% to nearly 50% depending on 
the assessment measurement ranging from 
structured interviews applied for clinical 
diagnosis to self-answered survey questions, 
respectively.5 Furthermore, several system-
atic reviews have shown that depression is an 
independent risk factor for cardiac mortality6 
as well as all-cause mortality.7 8 In addition, 
the evidence suggests that when depression 
and CVD present together, they have a signif-
icant influence on both medical costs and 
service delivery.9
Cardiac rehabilitation (CR) is a multi-
component intervention that incorporates 
secondary prevention for CVD.10 11 Recent 
systematic reviews have shown that CR is an 
effective intervention12 13 and reduces depres-
sive symptoms.14 Two cohort studies have 
also shown the impact of CR on reducing 
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depression levels in patients with CVD15 16 in accordance 
with a literature review.17 The management of psychoso-
cial health has been promoted in recent guidelines and 
the importance of multicomponent CR programmes 
highlighted.18 19 Thus, a measure of psychosocial health 
status is required to assess and manage depression symp-
toms among CR participants. Hospital Anxiety and 
Depression Scale (HADS) is used in the UK context and 
applied before and after CR to tailor interventions consid-
ering patient’s needs.20 HADS is a valid measurement of 
depressive symptoms in CVD populations in the UK and 
also in other countries.21 Most prior studies have focused 
on depressive symptoms associated with the acute event, 
and there is very little evidence on the influence of prior 
history of depression.8 In addition, some studies have 
shown that patients with CVD with comorbid depression 
prior to their heart event were at increased risk in terms of 
mortality and poor cardiac prognosis.22 23 Therefore, we 
aim to identify and evaluate sociodemographic and clin-
ical characteristics associated with depression outcome in 
patients with historic comorbid depression following CR.
METHODS
An observational study of routine practice across 
England, Wales and Northern Ireland using the British 
Heart Foundation National Audit of Cardiac Rehabilita-
tion (NACR) is employed. The checklist ‘Strengthening 
the reporting of observational studies in epidemiology’ 
(STROBE) is followed to report this study.24
Data collection
NACR data are used to perform the analysis. The NACR 
is responsible for monitoring the UK CR services and 
improving the quality of these programmes. The data 
regarding patient’s demographics and clinical charac-
teristics are collected via CR programmes and entered 
by the approved member of clinical teams to a secure 
online platform, NHS digital, under the section 251 
approval. Baseline and post-CR assessments are routinely 
conducted and then data are link-anonymised and trans-
ferred to NACR located at the University of York. A total 
of 224 CR services provide data which constitutes 74% of 
all programmes in the UK.20 The data include patients 
who participated in CR along with details of their initi-
ating event, treatment, demographics, risk factors, medi-
cation and outcomes.
Participants
The data of the last 5 years based on NACR—1 April 
2012 to 31 March 2017—were extracted and analysed. 
CR guidelines have recommended the inclusion of 
patients with myocardial infarction and heart failure and 
those who receive treatment of percutaneous coronary 
intervention and coronary artery bypass graft,25 which 
constituted the study population. All the eligible patients 
(N=2715) with comorbid depression who had pre-HADS 
and post-HADS assessments in CR were selected as partic-
ipants during the study period.
Measures
Comorbid depression
Comorbid depression is operationalise here as a 
medical history of depression in the NACR data which 
is confirmed by CR practitioners with case note review 
and also by patients in terms of whether they have ever 
been diagnosed or treated by a doctor for depression. 
Therefore, comorbid depression is defined in the paper 
as depression history prior to heart event.
Hospital Anxiety and Depression Scale
The HADS is a self-answered screening tool to measure 
depressive symptoms which is widely used in many clin-
ical populations. In a recent CR guideline, psychosocial 
health assessments, using HADS, are recommended 
to be applied before and after CR to tailor the inter-
ventions to cardiac patients.18 The HADS is a validated 
measure licensed to NACR for the assessment of anxiety 
and depression symptoms and is recommended for use 
with patients with CVD.21 The HADS is scored between 
0 and 21 where a higher score is associated with worse 
symptoms.26 The clinical cut-off point of 8 is used to 
categorise patients to low levels of depression (<8) and 
higher depression groups (≥8).21 Statistical analyses were 
conducted comparing patients with HADS <8 and HADS 
≥8 in a subgroup of patients with comorbid depres-
sion. Baseline HADS anxiety scores, which are routinely 
reported as part of HADS, were assessed to see whether it 
predicts depression outcomes following CR.
Total number of comorbidities
Total number of comorbidities are defined as the 
sum of the number of comorbidities that the patients 
had including hypertension, hypercholesterolaemia, 
diabetes, angina, arthritis, osteoporosis, asthma, chronic 
bronchitis and others. There are 19 different comorbidi-
ties in the NACR data.
Physical activity
Physical activity was measured by the question of “Do 
you take regular moderate physical activity of at least 30 
min duration on average 5 times a week?” which requires 
an answer of ‘yes’ or ‘no’. This gives the proportion of 
moderate physical activity. Moderate activity is explained 
in the questionnaire as anything that takes as much effort 
as brisk walking or housework, carrying a light bag on 
level ground, mowing the lawn, painting and decorating, 
sports like easy swimming, easy cycling or hobbies such as 
ballroom dancing.
Smoking
Baseline smoking measurements are categorised as to 
whether a patient smokes or not. If patients never smoked, 
ex-smoker or stopped smoking since the heart event, they 
are categorised as non-smoking at baseline and if they 
were currently smoking categorised as smoking. Self-re-
ported smoking is a valid measurement and shows similar 
results with biochemical smoking assessments.27
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Figure 1 Flow diagram for study sampling. CR, cardiac 
rehabilitation; HADS, Hospital Anxiety and Depression Scale; 
NACR, National Audit of Cardiac Rehabilitation.
Table 1 Baseline characteristics for high and low HADS 
depression groups
Variables
HADS 
<8 group 
(n=1494)
HADS 
≥8 group 
(n=1221) P 
value
Effect 
sizeMean±SD Mean±SD
Age 63.49±10.50 60.77±10.53 <0.001 0.26
Total comorbidities 4.39±2.10 4.90±2.19 <0.001 0.24
Weight 83.62±17.04 85.56±19.08 0.001 0.11
HADS anxiety score 
measurement
6.43±3.80 11.60±4.05 <0.001 1.32
Gender male % 66.4 66.4 0.99 0
150 min physical 
activity a week 
(yes) %
43.6 27.5 <0.001 0.17
Smoking (yes) % 7.7 12.7 <0.001 0.08
Partnered % 71.5 63.6 <0.001 0.08
HADS, Hospital Anxiety and Depression Scale.
Weight
Weight was measured in kilograms. It is measured by CR 
programmes.
Marital status
Marital status was determined by whether patients have 
a partner or not at baseline. Patients who are married 
or have permanent partnership were categorised into 
partnered and the ones who are single, divorced, 
widowed and separated categorised into not-partnered 
or single.
Statistical analysis
SPSS V.24 is used to conduct the data analysis. Patients 
with comorbidity depression who have valid pre-HADS 
and post-HADS assessments constituted the study popu-
lation. Statistical significance was set to 5%. Summary 
statistics were presented as mean and SD unless other-
wise stated. Baseline characteristic for the variables of 
age, number of comorbidities, weight, HADS anxiety 
measurement, gender, physical activity, smoking and 
marital status were investigated. Using these variables, 
defined from the literature and baseline assessments, 
binary logistic regression were conducted to see which 
of these variables predict change in HADS depressive 
symptoms. We investigated which baseline characteristics 
predict moving to low levels of depressive symptoms in 
comparison with remaining with higher depressive symp-
toms after CR.
Ethics
Approved members of clinical teams enter NACR data 
to NHS digital which is a secure online environment 
that meets General Data Protection Regulation (GDPR) 
requirements. NHS digital has the approval to collect the 
patient-identifiable data which is then link anonymised 
and sent electronically to NACR for the quality valida-
tion of the data. As part of NHS digital contract, data on 
pre-CR and post-CR assessments and characteristics of 
patients are collected for the purpose of audit and service 
improvement. On this basis no separate ethical approval 
was required.
RESULTS
The study population was 2715 participants with 
comorbid depression who have completed CR with valid 
pre-HADS and post-HADS assessments. Of these 2715 
participants, 55% had low level of depressive symptoms 
(HADS <8) and 45% had a higher level of depressive 
symptoms (HADS ≥8). The flow diagram in figure 1 shows 
the total population in the time period and sample size 
of our study. At baseline, participants with higher depres-
sive symptoms group were younger, had higher number 
of comorbidities, increased weight, higher anxiety, were 
less physically active, more likely to be smoker and single. 
Baseline characteristics of participants in the context of 
HADS are presented in table 1.
A binominal logistic regression was performed to ascer-
tain the impact of age, gender, weight, total number of 
comorbidities, HADS anxiety measurement, physical 
activity, smoking and marital status on the likelihood that 
participants move to low levels of depression group over 
the ones who remain in the higher levels of depression 
symptoms group after CR. The logistic regression model 
was statistically significant, χ2(8)=72.193, p<0.001. The 
model correctly classified 63.3% of the cases. Hosmer 
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Table 2 Coeficients of the model predicting change in depression whether a patient has moved to low levels of depressive 
symptoms group after CR
Variable B SE P value Lower 95% CI OR
Upper 95% 
CI
Age −0.002 0.008 0.765 0.983 0.998 1.013
Total no of comorbidities −0.090 0.035 0.010 0.854 0.914 0.979
Weight −0.004 0.004 0.363 0.988 0.996 1.004
HADS anxiety score measurement −0.124 0.019 <0.001 0.851 0.883 0.917
150 min a week physical activity (no) −0.347 0.162 0.033 0.514 0.707 0.971
Smoking (no) 0.573 0.250 0.022 1.086 1.774 2.898
Gender (male) −0.328 0.163 0.045 0.523 0.721 0.992
Marital status (single) −0.088 0.155 0.570 0.677 0.916 1.240
B, regression coeficient;CR, cardiac rehabilitation.
and Lemeshow test shows that the model was a good fit 
(p=0.288). Of the eight predictor variables, five were 
statistically significant: total number of comorbidities, 
HADS anxiety score measurement, physical activity, 
smoking and gender (as shown in table 2).
Patients with higher number of comorbidities had 0.914 
times lower odds of residing in low levels of depressive 
symptoms after CR (OR 0.914, 95% CI 0.854 to 0.979). 
Increased HADS anxiety score measurement was associ-
ated with a decreased likelihood of moving to low levels 
of depressive symptoms group after CR (OR 0.883, 95% 
CI 0.851 to 0.917). Physical inactivity and male gender 
were also associated with reduced odds of becoming low 
depression level category (with OR 0.707, 95% CI 0.514 to 
0.971 and OR 0.721, 95% CI 0.523 to 0.992, respectively), 
whereas non-smoking was associated with increased like-
lihood of having low HADS range after CR (OR 1.774, 
95% CI 1.086 to 2.898).
DISCUSSION
Prior studies have tackled certain elements of the asso-
ciation between depressive symptoms and lifestyle risk 
factors along with patient demographics. However, the 
impact of comorbid depression was not clear. Therefore, 
in the current study, the influence of comorbid depres-
sion in patients with CVD has been evaluated to a greater 
extent through a robust approach. The results of our 
study has shown that baseline characteristics of partici-
pants with comorbid depression determine outcome 
following CR. These characteristics such as having 
higher total number of comorbidities, higher anxiety 
scores, physical inactivity, smoking and male gender were 
significant predictors of depression outcomes after CR. 
However, age, weight and marital status were not able to 
determine depressive symptoms following CR in patients 
with a history of comorbid depression.
Our findings which are unique by virtue of being based 
on routine clinical practice data support the previous 
cohort and trial studies which have shown the association 
with physical inactivity28 29 and smoking,30 31 with higher 
depressive symptoms. One additional finding of note was 
that baseline anxiety scores had an impact on depression 
outcomes (p<0.001, OR 0.883, 95% CI 0.851 to 0.917). 
One recent study has shown that anxiety and depression 
are, when presented together, associated with increased 
mortality rates after CR (HR 2.41, p=0.04).32 Our study 
shows that baseline anxiety scores of patients with history 
of depression predicts outcome after CR. Patients with 
history of depression are also more likely to remain 
depressed when they have high anxiety scores at base-
line. Therefore, participants’ anxiety levels at baseline 
may be an important CR intervention focus for reducing 
mortality rates in patients with comorbid depression 
history. Further studies assessing the effectiveness of such 
interventions would be valuable.
Higher total number of comorbidities was also a signif-
icant predictor of depressive symptoms in our study 
(OR 0.914, 95% CI 0.854 to 0.979), although one other 
study has stated the opposite in the general popula-
tion.33 However, a recent study has shown that increased 
number of comorbidities limit cardiac patients’ physical 
activity and correspondingly reduce their quality of life34; 
perhaps this may mediate having higher depressive symp-
toms as a consequence. In addition, this association of 
higher number of comorbidities with higher depressive 
symptoms also becomes a salient finding considering that 
19 different comorbidities were included in the NACR 
data such as hypertension, hypercholesterolaemia, 
diabetes, angina, arthritis, osteoporosis, asthma, chronic 
bronchitis and others. Besides, the findings of another 
study were also in line with this which has shown the asso-
ciation of comorbidities with depressive symptoms in the 
general population of older adults in western European 
countries.35
A recent meta-analysis which included 49 prospective 
studies with a sample around 267 000 individuals has 
shown that physical activity had a protective effect on 
incident depression regardless of geographical region 
in the general population (OR 0.83, 95% CI 0.79 to 
0.88).36 However, our study adds, given prior depression 
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history, cardiac patients who are less physically active 
were 30% less likely to move to low levels of depressive 
symptoms group after CR (OR 0.707, 95% CI 0.514 to 
0.971). Another clinically important finding was that, as 
an important lifestyle risk factor, smoking was influen-
tial on CR outcomes. The present study has shown that 
participants who are non-smokers at baseline were 77% 
more likely to move to low levels of depression symptoms 
group after CR (OR 1.774, 95% CI 1.086 to 2.898). The 
results of a recent systematic review has also supported 
the association of smoking with depressive symptoms in 
the general population.37 A total of 148 cohort studies 
included in this review and a third of included studies 
explored the association between smoking status with 
later depression. Of these studies, 73% of them have 
found evidence to support this association. Our findings 
have supported this association in patients with CVD who 
participated in CR programmes in routine CR practice.
One finding was that age was not a significant deter-
minant of depression (OR 0.998, 95% CI 0.983 to 1.013) 
as it was in a prior study concluding that patients with 
higher depressive symptoms were younger.38 Although 
this relationship was seen at baseline, age was not able 
to predict outcome after adjusting for other covariates 
in our model. Unlike prior studies, weight did not have 
a potential impact on depressive symptoms.39 A possible 
explanation for this might be that we have accounted for 
total number of comorbidities which could be predic-
tive of weight change.40 Furthermore, marital status in 
patients was not able to predict depressive symptoms (OR 
0.916, 95% CI 0.677 to 1.240) which differs from find-
ings observed in the general population.41 Although this 
association was observed at baseline, adjusting for other 
covariates it no longer reached statistical significance in 
the final model. A recent prospective study in Finland 
found an association between increased marriage dissat-
isfaction and risk of sudden cardiac death among men 
(HR 1.90, 95% CI 1.09 to 3.32).42 The NACR does not 
have information of the satisfaction of patients on their 
marriage; however, this could be an important factor 
for further studies to consider rather than looking at 
whether patients have a partner or not. A finding was 
that men were less likely to gain improvement in their 
depressive symptoms than women in our comorbid 
depression sample (OR 0.721, 95% CI 0.523 to 0.992). 
This result differs from a previous study.43 Although we 
have included more women in our study (33.6%), their 
mean age was lower, by 3 years, which makes it hard to 
explain this result. However, proportion of male smokers 
was higher than female smokers in our sample which may 
have an impact on the result as smoking is associated with 
higher levels of depression.
An important finding for clinical practice was that 
60%–65% (N=5110) of patients in routine practice with 
comorbid depression did not have recorded pre-CR and 
post-CR HADS measurements. Clinical guidance across 
the globe recommend that psychosocial health status is 
assessed before and after rehabilitation.18 19 As our study 
shows, HADS measurement, in patients with prior history 
of depression, informs patient outcomes. Therefore, CR 
programmes need to be aware of this and aim to carry 
out and record psychosocial assessment before and after 
CR. Our study is the first to establish this in the UK CR 
programmes.
Limitations
One limitation is that our population is a subgroup of 
those with a pre-existing diagnosis of depression. This 
is because we wanted to test what are the characteristics 
of patients with comorbid depression determining CR 
outcome. However, when looking at our population, it 
is representative of all available patients with comorbid 
depression as patient demographics were similar between 
our sample and all available participants with comorbid 
depression (mean age was 62 compared with 61 and 
33.6% women compared with 35%), and this propor-
tion did not differ more than 5% for other variables. 
Although the sample was nationally representative of 
patients with comorbid depression around the UK, it is 
important to state that not all CR programmes in the UK 
provide a complete record of patients who completed 
CR. As many as 38% did not have follow-up assessment in 
NACR data which may have an impact on the representa-
tiveness of the sample.20 However, an observational study 
enabled us to understand what happens in the real world 
by analysing routinely collected data which is one of its 
main strengths. In addition, the data included patients 
with multi-comorbidities and more female participants 
than prior RCTs.12
CONCLUSION
An initial objective of the project was to identify which 
factors determine the depressive symptoms in patients 
with comorbid depression in CR. Baseline characteris-
tics of patients with comorbid depression such as higher 
anxiety, higher total number of comorbidities, smoking, 
physical inactivity and male gender were associated with 
their depression levels following CR. CR programmes 
need to be aware of this specific population of patients 
with comorbid depression and their characteristics to 
improve CR outcomes. CR programmes should target 
HADS measurements towards patients with comorbid 
depression and give importance to recording as part of 
routine practice. As this is the first study investigating 
history of depression in CR literature, further studies on 
the current topic are therefore recommended to build 
on our findings.
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